| MDS Inc. is a life sciences company that provides products and services that its customers need for the development of drugs and the diagnosis and treatment of disease. The Company is a provider of pharmaceutical research services, medical isotopes for molecular imaging, sterilization, radiotherapeutics and analytical instruments. MDS operates in three business units within the life sciences industry: MDS Pharma Services; MDS Nordion, and MDS Analytical Technologies. The Company operates under three business units: MDS Pharma Services, MDS Nordion and MDS Analytical Technologies. On February 26, 2007, the Company sold its remaining Canadian diagnostics businesses to Borealis Infrastructure Management Inc. On March 20, 2007, the Company acquired Molecular Devices Corporation. In June 2008, the Company's unit, MDS Analytical Technologies, acquired Blueshift Biotechnologies. |
